Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 40.50
-0.90 (-2.17%)
Aug 6, 2026, 10:38 AM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 8.28 billion as of August 5, 2026. Its market cap has increased by 88.23% in one year.
Market Cap
8.28B
Enterprise Value
7.83B
Revenue
12.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.50
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has decreased from 9.88B to 8.28B, a decrease of -16.17%. That is a compound annual growth rate of -4.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 8.28B | 44.00% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 10.07B |
| Gongwin Biopharm Holdings | 9.68B |
| Polaris Group | 9.63B |
| TCM Biotech International | 9.48B |
| PharmaEngine | 8.82B |
| AP Biosciences | 8.65B |
| Adimmune | 7.08B |
| Acepodia | 6.99B |